vs 7,393 other HR bills in the 115th — cohort avg 50d
Summary
ALS Disability Insurance Access Act of 2017 This bill amends title II (Old Age, Survivors, and Disability Insurance) of the Social Security Act to eliminate the five-month waiting period for disability insurance benefits for individuals with amyotrophic lateral sclerosis (a progressive neurodegenerative disease, also known as Lou Gehrig's disease, that affects nerve cells in the brain and spinal cord). Under current law, individuals must wait five months after becoming disabled before their disability insurance benefit payments can begin.
Lobbying filings that explicitly cite this bill (21)
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Cited source text, amounts, lobbyists, and targets
ALS Disability Insurance Access Act (S.379/H.R.1171) to waive the five-month waiting period for patients with ALS before receiving benefits under Social Security Disability Insurance.
Ensuring Coverage for Patients with Pre-Existing Conditions Act (S.3388) to oppose the legislation and go further in supporting protections for insurance coverage for people with pre-existing conditions.
Cited source text, amounts, lobbyists, and targets
ALS Disability Insurance Access Act (S.379/H.R.1171) to waive the five-month waiting period for patients with ALS before receiving benefits under Social Security Disability Insurance.
Client expense: $21,000 · Firm income: Not reported
Cited source text, amounts, lobbyists, and targets
Health care issues affecting individuals with neuromuscular disease including therapy development, newborn screening, insurance coverage, and access to care.
Health care reform including H.R. 750 - Ensuring Access to Quality Complex Rehabilitation Technology Act of 2017; S. 379/H.R. 1171 - ALS Disability Insurance Access Act.
Newborn screening including the planned introduction of the reauthorization of the Newborn Screening Saves Lives Act.
Client expense: $30,000 · Firm income: Not reported
Government targets: Executive Office of the President (EOP), Federal Aviation Administration (FAA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE, Transportation, Dept of (DOT)
Cited source text, amounts, lobbyists, and targets
Health care issues affecting individuals with neuromuscular disease, including therapy development and newborn screening.
Health care reform including H.R. 750 - Ensuring Access to Quality Complex Rehabilitation Technology Act of 2017; S. 379/H.R. 1171 - ALS Disability Insurance Access Act
Client expense: $30,000 · Firm income: Not reported
Government targets: Executive Office of the President (EOP), Federal Aviation Administration (FAA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE, Transportation, Dept of (DOT)
Cited source text, amounts, lobbyists, and targets
ALS Disability Insurance Access Act (S.379/H.R.1171) to waive the five-month waiting period for patients with ALS before receiving benefits under Social Security Disability Insurance.
Client expense: $10,000 · Firm income: Not reported
Cited source text, amounts, lobbyists, and targets
ALS Disability Insurance Access Act (S.379/H.R.1171) to waive the five-month waiting period for patients with ALS before receiving benefits under Social Security Disability Insurance.
Ensuring Coverage for Patients with Pre-Existing Conditions Act (S.3388) to oppose the legislation and go further in supporting protections for insurance coverage for people with pre-existing conditions.
Client expense: $10,000 · Firm income: Not reported
Cited source text, amounts, lobbyists, and targets
ALS Disability Insurance Access Act (S.379/H.R.1171) to waive the five-month waiting period for patients with ALS before receiving benefits under Social Security Disability Insurance.
Client expense: $10,000 · Firm income: Not reported
Cited source text, amounts, lobbyists, and targets
ALS Disability Insurance Access Act (S.379/H.R.1171) to waive the five-month waiting period for patients with ALS before receiving benefits under Social Security Disability Insurance.
Client expense: $10,000 · Firm income: Not reported
Cited source text, amounts, lobbyists, and targets
ALS Disability Insurance Access Act (S.379/H.R.1171) to waive the five-month waiting period for patients with ALS before receiving benefits under Social Security Disability Insurance.
Client expense: $10,000 · Firm income: Not reported
Cited source text, amounts, lobbyists, and targets
ALS Disability Insurance Access Act (S.379/H.R.1171) to waive the five-month waiting period for patients with ALS before receiving benefits under Social Security Disability Insurance.
Steve Gleason Enduring Voices Act (S.1132 and H.R.2465) to permanently fix the current Centers for Medicare and Medicaid Services (CMS) policy limiting access to Speech Generating Devices (SGD) for people with degenerative diseases like ALS.
Client expense: $10,000 · Firm income: Not reported
Cited source text, amounts, lobbyists, and targets
Health care issues affecting individuals with neuromuscular disease, including therapy development and newborn screening.
Health care reform including H.R. 750 - Ensuring Access to Quality Complex Rehabilitation Technology Act of 2017; S. 379/H.R. 1171 - ALS Disability Insurance Access Act
Client expense: $50,000 · Firm income: Not reported
Government targets: Executive Office of the President (EOP), Federal Aviation Administration (FAA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE, Transportation, Dept of (DOT)
Cited source text, amounts, lobbyists, and targets
Health care issues affecting individuals with neuromuscular disease, including therapy development and newborn screening.
Health care reform including H.R. 750 - Ensuring Access to Quality Complex Rehabilitation Technology Act of 2017; S. 379/H.R. 1171 - ALS Disability Insurance Access Act
Client expense: $50,000 · Firm income: Not reported
Government targets: Executive Office of the President (EOP), Federal Aviation Administration (FAA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE, Transportation, Dept of (DOT)
Cited source text, amounts, lobbyists, and targets
ALS Disability Insurance Access Act (S.379/H.R.1171) to waive the five-month waiting period for patients with ALS before receiving benefits under Social Security Disability Insurance.
Client expense: $10,000 · Firm income: Not reported
Cited source text, amounts, lobbyists, and targets
ALS Disability Insurance Access Act (S.379/H.R.1171) to waive the five-month waiting period for patients with ALS before receiving benefits under Social Security Disability Insurance.
Client expense: $10,000 · Firm income: Not reported
Cited source text, amounts, lobbyists, and targets
Health care issues affecting individuals with neuromuscular disease, including transitional health care, drug development, and newborn screening.
Health care reform including H.R. 1628 - the American Health Care Act (AHCA) of 2017 and the Better Care Reconciliation Act (BCRA); H.R. 750 - Ensuring Access to Quality Complex Rehabilitation Technology Act of 2017; S. 379/H.R. 1171 - ALS Disability Insurance Act
Client expense: $50,000 · Firm income: Not reported
Government targets: Executive Office of the President (EOP), Federal Aviation Administration (FAA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE, Transportation, Dept of (DOT)
Cited source text, amounts, lobbyists, and targets
Health care issues affecting individuals with neuromuscular disease, including transitional health care, drug development, and newborn screening.
H.R.2430/S. 934/P.L. 115-52 - FDA Reauthorization Act of 2017; H.R. 1628 - the American Health Care Act (AHCA) of 2017; the Better Care Reconciliation Act (BCRA); H.R. 750 - Ensuring Access to Quality Complex Rehabilitation Technology Act of 2017; S. 818/H.R. 1896 - ABLE to Work Act; S. 816/H.R. 1897 - ABLE Financial Planning Act; S. 817/H.R. 1874 - ABLE Age Adjustment Act; H.R. 529 - 529 and ABLE Account Improvement Act; S. 379/H.R. 1171 - ALS Disability Insurance Act
Client expense: $80,000 · Firm income: Not reported
Government targets: Executive Office of the President (EOP), Federal Aviation Administration (FAA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE, Transportation, Dept of (DOT)
Cited source text, amounts, lobbyists, and targets
115th H.R. 1171 and S. 408 - Presidential Trade Transparency Act
115th H.R. 133 - To reduce Federal spending and the deficit by terminating taxpayer financing of Presidential election campaigns
115th H.R. 371 and S. 65 - Presidential Conflicts of Interest Act
Constitutional amendments addressing Citizens United v. FEC and McCutcheon v. FEC, and related cases, especially the Democracy for All Amendment (115th H.J.Res. 31 and S.J.Res. 8), but also including 115th H.J.Res. 90
Executive and judicial nominations and appointments, including both individuals and rules/procedures
Opposition to a Goodlatte proposal that would have gutted the Office of Congressional Ethics and ethics enforcement in the House: opposition to the language itself and to the House rules package (as passed by the House Republican Conference and later introduced as 115th H.Res. 5) as long as that language remained intact
Opposition to the undermining of the Office of Government Ethics and the political targeting of Director Walter Shaub; Deferral of any inquiry into the Office by the House Committee on Oversight and Government Reform until such time as it is bipartisan, held in public, addresses the Trump administrations potential conflicts of interest, and is calibrated to interfere as little as possible with the Office's ongoing activities of reviewing the incoming administrations compliance with ethical requirements
Recommendations regarding the Department of Educations Office for Civil Rights (OCR) and the agencys Assistant Secretary for Civil Rights
Recommendations regarding the Department of Justice's Civil Rights Division and the agencys Assistant Attorney General for Civil Rights
Requesting the Attorney General to immediately and completely recuse himself from all Department of Justice investigations and actions regarding any interactions between President Donald Trump, his campaign staff, or other individuals supporting his campaign and Russian actors during Trumps 2016 presidential campaign; any Russian interference with the 2016 presidential election; the activities of former National Security Adviser Michael Flynn and Russian actors; and any leaks concerning these matters
Cited source text, amounts, lobbyists, and targets
Health care issues affecting individuals with neuromuscular disease, including transitional health care, drug development, and newborn screening.
H.R.2430 - FDA Reauthorization Act of 2017; H.R. 1628 - the American Health Care Act (AHCA) of 2017; the Better Care Reconciliation Act (BCRA); H.R. 750 - Ensuring Access to Quality Complex Rehabilitation Technology Act of 2017; S. 818/H.R. 1896 - ABLE to Work Act; S. 816/H.R. 1897 - ABLE Financial Planning Act; S. 817/H.R. 1874 - ABLE Age Adjustment Act; H.R. 529 - 529 and ABLE Account Improvement Act; S. 379/H.R. 1171 - ALS Disability Insurance Act
Client expense: $120,000 · Firm income: Not reported
Government targets: Executive Office of the President (EOP), Federal Aviation Administration (FAA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE, Transportation, Dept of (DOT)
Cited source text, amounts, lobbyists, and targets
115th H.R. 1171 and S. 408 - Presidential Trade Transparency Act
115th H.R. 133 - To reduce Federal spending and the deficit by terminating taxpayer financing of Presidential election campaigns
115th H.R. 371 and S. 65 - Presidential Conflicts of Interest Act
Constitutional amendments addressing Citizens United v. FEC and McCutcheon v. FEC, and related cases, especially the Democracy for All Amendment (115th H.J.Res. 31 and S.J.Res. 8), but also including 115th H.J.Res. 90
Executive and judicial nominations and appointments, including both individuals and rules/procedures
Opposition to a Goodlatte proposal that would have gutted the Office of Congressional Ethics and ethics enforcement in the House: opposition to the language itself and to the House rules package (as passed by the House Republican Conference and later introduced as 115th H.Res. 5) as long as that language remained intact
Opposition to the undermining of the Office of Government Ethics and the political targeting of Director Walter Shaub; Deferral of any inquiry into the Office by the House Committee on Oversight and Government Reform until such time as it is bipartisan, held in public, addresses the Trump administrations potential conflicts of interest, and is calibrated to interfere as little as possible with the Office's ongoing activities of reviewing the incoming administrations compliance with ethical requirements
Recommendations regarding the Department of Educations Office for Civil Rights (OCR) and the agencys Assistant Secretary for Civil Rights
Recommendations regarding the Department of Justice's Civil Rights Division and the agencys Assistant Attorney General for Civil Rights
Requesting the Attorney General to immediately and completely recuse himself from all Department of Justice investigations and actions regarding any interactions between President Donald Trump, his campaign staff, or other individuals supporting his campaign and Russian actors during Trumps 2016 presidential campaign; any Russian interference with the 2016 presidential election; the activities of former National Security Adviser Michael Flynn and Russian actors; and any leaks concerning these matters
Cited source text, amounts, lobbyists, and targets
Health care issues affecting individuals with neuromuscular disease, including transitional health care, drug development, and appropriations issues, newborn screening, reauthorization of the Prescription Drug User Fee Act (PDUFA), and health care reform (H.R. 1628, American Health Care Act of 2017)
H.R. 1223, Orphan Products Extension Now Accelerating Cures and Treatments Act of 2017 (OPEN Act); S. 486/H.R. 750, Ensuring Access to Quality Complex Rehabilitation Technology Act of 2015; S. 818/H.R. 1896, ABLE to Work Act; S. 816/H.R. 1897, ABLE Financial Planning Act; S. 817/H.R. 1874, ABLE Age Adjustment Act; H.R. 529, 529 and ABLE Account Improvement Act; S. 379/H.R. 1171, ALS Disability Insurance Act
Client expense: $80,000 · Firm income: Not reported
Government targets: Executive Office of the President (EOP), Federal Aviation Administration (FAA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE, Transportation, Dept of (DOT)
Cited source text, amounts, lobbyists, and targets
115th H.R. 1171 and S. 408 - Presidential Trade Transparency Act
115th H.R. 133 - To reduce Federal spending and the deficit by terminating taxpayer financing of Presidential election campaigns
115th H.R. 371 and S. 65 - Presidential Conflicts of Interest Act
Constitutional amendments addressing Citizens United v. FEC and McCutcheon v. FEC, and related cases, especially the Democracy for All Amendment (115th H.J.Res. 31 and S.J.Res. 8), but also including 115th H.J.Res. 90
Executive and judicial nominations and appointments, including both individuals and rules/procedures
Opposition to a Goodlatte proposal that would have gutted the Office of Congressional Ethics and ethics enforcement in the House: opposition to the language itself and to the House rules package (as passed by the House Republican Conference and later introduced as 115th H.Res. 5) as long as that language remained intact
Opposition to the undermining of the Office of Government Ethics and the political targeting of Director Walter Shaub; Deferral of any inquiry into the Office by the House Committee on Oversight and Government Reform until such time as it is bipartisan, held in public, addresses the Trump administrations potential conflicts of interest, and is calibrated to interfere as little as possible with the Office's ongoing activities of reviewing the incoming administrations compliance with ethical requirements
Recommendations regarding the Department of Educations Office for Civil Rights (OCR) and the agencys Assistant Secretary for Civil Rights
Recommendations regarding the Department of Justice's Civil Rights Division and the agencys Assistant Attorney General for Civil Rights
Requesting the Attorney General to immediately and completely recuse himself from all Department of Justice investigations and actions regarding any interactions between President Donald Trump, his campaign staff, or other individuals supporting his campaign and Russian actors during Trumps 2016 presidential campaign; any Russian interference with the 2016 presidential election; the activities of former National Security Adviser Michael Flynn and Russian actors; and any leaks concerning these matters
Government targets: Education, Dept of, HOUSE OF REPRESENTATIVES, Justice, Dept of (DOJ), Office of Management & Budget (OMB), President of the U.S., SENATE, White House Office
Client expense: $60,000 · Firm income: Not reported
Government targets: Education, Dept of, HOUSE OF REPRESENTATIVES, Justice, Dept of (DOJ), Office of Management & Budget (OMB), President of the U.S., SENATE, White House Office
Client expense: $60,000 · Firm income: Not reported
Government targets: Education, Dept of, HOUSE OF REPRESENTATIVES, Justice, Dept of (DOJ), Office of Management & Budget (OMB), President of the U.S., SENATE, White House Office